[{"id":"c358d7e4-427f-4382-9fc0-367764b779e6","acronym":"RACTAC","url":"https://clinicaltrials.gov/study/NCT04224441","created_at":"2021-01-27T20:01:13.963Z","updated_at":"2024-07-02T16:36:51.430Z","phase":"Phase 2","brief_title":"Repurposing Chlorpromazine in the Treatment of Glioblastoma","source_id_and_acronym":"NCT04224441 - RACTAC","lead_sponsor":"Marco G Paggi, MD, PhD","biomarkers":" IDH2 • MGMT","pipe":"","alterations":" ","tags":["IDH2 • MGMT"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e temozolomide • chlorpromazine"],"overall_status":"Recruiting","enrollment":" Enrollment 41","initiation":"Initiation: 12/15/2019","start_date":" 12/15/2019","primary_txt":" Primary completion: 06/15/2022","primary_completion_date":" 06/15/2022","study_txt":" Completion: 12/15/2022","study_completion_date":" 12/15/2022","last_update_posted":"2020-01-13"}]